Tata Nifty MidSmall Healthcare Index Fund Regular-Growth
Mid CapEquity: Sectoral-Pharmaअतिशय जास्त जोखीम
PaisaSmart रेटिंग★★★★★0
हे रेटिंग का
This index fund/ETF has a beta of nan%, and an expense ratio of 1.12%, giving it a 0.0 star rating, based on the principle that lower values of |1-beta| and expense ratio result in higher ratings.
आमचा स्कोअर दीर्घकालीन कामगिरी, जोखीम आणि सातत्य यांचे वजन करतो — फक्त मागील परतावे नाही.
परतावा
8 Oct 2026 पर्यंत
1W
-2.58%
1M
-5.94%
3M
-0.54%
6M
+15.93%
9M
+11.20%
1Y
+12.37%
2Y
+7.68%
सुरुवातीपासून
+15.86%
पोर्टफोलिओ
31 Aug 2026 पर्यंत
मार्केट-कॅप विभागणी
मिड कॅप67.51%स्मॉल कॅप32.49%
P/E
38.29
P/B
4.80
शैली
Growth
क्षेत्रनिहाय वाटप
Healthcare100.13%
होल्डिंग्स (31)
| होल्डिंग | फंडाचा % | मूल्य | शेअर्स |
|---|---|---|---|
| Laurus Labs Ltd. | 11.22% | ₹24.59 Cr | 1,28,402 |
| Lupin Ltd. | 8.01% | ₹17.54 Cr | 80,145 |
| Aurobindo Pharma Ltd. | 7.16% | ₹15.68 Cr | 91,348 |
| Fortis Healthcare Ltd. | 7.12% | ₹15.6 Cr | 1,71,978 |
| Glenmark Pharmaceuticals Ltd. | 5.62% | ₹12.32 Cr | 49,690 |
| Alkem Laboratories Ltd. | 4.70% | ₹10.29 Cr | 19,310 |
| Biocon Ltd. | 4.43% | ₹9.7 Cr | 2,35,451 |
| Ipca Laboratories Ltd. | 4.13% | ₹9.05 Cr | 45,841 |
| Mankind Pharma Ltd. | 4.13% | ₹9.04 Cr | 37,362 |
| Gland Pharma Ltd. | 3.46% | ₹7.59 Cr | 26,296 |
फंड तपशील
थोडक्यात
Long Term Capital Appreciation. Investment in equity and equity related instruments comprised in Nifty MidSmall Healthcare Index.
गुंतवणूक उद्दिष्ट
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
एक्झिट लोड
Exit load of 0.25%, if redeemed within 15 days.
फंड प्रकार
Open-ended
किमान एकरकमी
₹5,000
किमान काढणी
₹500
लॉक-इन
नाही
SIP
उपलब्ध
SWP
उपलब्ध
STP
उपलब्ध
खरेदी कट-ऑफ
15:00